Cargando…

Defining early changes in Alzheimer’s disease from RNA sequencing of brain regions differentially affected by pathology

Tau pathology in Alzheimer’s disease (AD) spreads in a predictable pattern that corresponds with disease symptoms and severity. At post-mortem there are cortical regions that range from mildly to severely affected by tau pathology and neuronal loss. A comparison of the molecular signatures of these...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guennewig, Boris, Lim, Julia, Marshall, Lee, McCorkindale, Andrew N., Paasila, Patrick J., Patrick, Ellis, Kril, Jillian J., Halliday, Glenda M., Cooper, Antony A., Sutherland, Greg T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7921390/ https://www.ncbi.nlm.nih.gov/pubmed/33649380 http://dx.doi.org/10.1038/s41598-021-83872-z

Ejemplares similares

Author Correction: Defining early changes in Alzheimer’s disease from RNA sequencing of brain regions differentially affected by pathology
por: Guennewig, Boris, et al.
Publicado: (2021)

Author Correction: Defining early changes in Alzheimer’s disease from RNA sequencing of brain regions differentially affected by pathology
por: Guennewig, Boris, et al.
Publicado: (2023)

The Key Factors Predicting Dementia in Individuals With Alzheimer’s Disease-Type Pathology
por: McCorkindale, Andrew N., et al.
Publicado: (2022)

Vascular Dysfunction Is Central to Alzheimer’s Disease Pathogenesis in APOE e4 Carriers
por: McCorkindale, Andrew N., et al.
Publicado: (2022)

Ranking the risk factors for Alzheimer’s disease; findings from the UK Biobank study
por: Allwright, Michael, et al.
Publicado: (2023)

Overlap between Central and Peripheral Transcriptomes in Parkinson’s Disease but Not Alzheimer’s Disease
por: Hooshmand, Kosar, et al.
Publicado: (2022)

The acute phase protein lactoferrin is a key feature of Alzheimer’s disease and predictor of Aβ burden through induction of APP amyloidogenic processing
por: Tsatsanis, Andrew, et al.
Publicado: (2021)

Synapses, Microglia, and Lipids in Alzheimer’s Disease
por: Paasila, Patrick J., et al.
Publicado: (2022)

Spread of pathology in amyotrophic lateral sclerosis: assessment of phosphorylated TDP-43 along axonal pathways
por: Fatima, Manaal, et al.
Publicado: (2015)

The pathogenesis of cingulate atrophy in behavioral variant frontotemporal dementia and Alzheimer’s disease
por: Tan, Rachel H, et al.
Publicado: (2013)

Periodontitis induces endothelial dysfunction in mice
por: Parvaneh, Maria, et al.
Publicado: (2021)

The cytokines interleukin-6 and interferon-α induce distinct microglia phenotypes
por: West, Phillip K., et al.
Publicado: (2022)

Ground state depletion microscopy as a tool for studying microglia–synapse interactions
por: Paasila, Patrick Jarmo, et al.
Publicado: (2021)

Classification of FTLD-TDP cases into pathological subtypes using antibodies against phosphorylated and non-phosphorylated TDP43
por: Tan, Rachel H, et al.
Publicado: (2013)

Antihypertensive medications ameliorate Alzheimer's disease pathology by slowing its propagation
por: Affleck, Andrew J., et al.
Publicado: (2020)

Machine learning analysis of the UK Biobank reveals IGF-1 and inflammatory biomarkers predict Parkinson’s disease risk
por: Allwright, Michael, et al.
Publicado: (2023)

Accelerated aging exacerbates a pre‐existing pathology in a tau transgenic mouse model
por: Bodea, Liviu‐Gabriel, et al.
Publicado: (2017)

Expanding the phenotypic associations of globular glial tau subtypes
por: Burrell, James R., et al.
Publicado: (2016)

Quantitative interpretation explains machine learning models for chemical reaction prediction and uncovers bias
por: Kovács, Dávid Péter, et al.
Publicado: (2021)

Structural core of the executive control network: A high angular resolution diffusion MRI study
por: Shen, Kai‐kai, et al.
Publicado: (2019)

Assessment of amyloid β in pathologically confirmed frontotemporal dementia syndromes
por: Tan, Rachel H., et al.
Publicado: (2017)

Glycoprotein Pathways Altered in Frontotemporal Dementia With Autoimmune Disease
por: Bright, Fiona, et al.
Publicado: (2021)

Rapid recruitment of large cohort to support trials in general practice: the role of FARSITE
por: Bower, Peter, et al.
Publicado: (2015)

Defining the Earliest Pathological Changes of Alzheimer’s Disease
por: Vickers, James C., et al.
Publicado: (2016)

Understanding the implementation of ‘sick day guidance’ to prevent acute kidney injury across a primary care setting in England: a qualitative evaluation
por: Martindale, Anne-Marie, et al.
Publicado: (2017)

Transcriptional dynamics of microRNAs and their targets during Drosophila neurogenesis
por: Menzel, Peter, et al.
Publicado: (2019)

Barriers and facilitators of adherence to the use of ASICA, a digital app designed to support people previously treated for melanoma: concise report of a qualitative study
por: Ntessalen, Maria, et al.
Publicado: (2023)

Tau-Mediated Nuclear Depletion and Cytoplasmic Accumulation of SFPQ in Alzheimer's and Pick's Disease
por: Ke, Yazi, et al.
Publicado: (2012)

Correction: Tau-Mediated Nuclear Depletion and Cytoplasmic Accumulation of SFPQ in Alzheimer's and Pick's Disease
por: Ke, Yazi, et al.
Publicado: (2012)

The role of sex differences in depression in pathologically defined Alzheimer’s disease
por: Tremblay, Cécilia, et al.
Publicado: (2023)

Recent Developments in TSPO PET Imaging as A Biomarker of Neuroinflammation in Neurodegenerative Disorders
por: Werry, Eryn L., et al.
Publicado: (2019)

Distribution Patterns of Astrocyte Populations in the Human Cortex
por: Forrest, Shelley L., et al.
Publicado: (2022)

The impact of fluticasone furoate/vilanterol on healthcare resource utilisation in the Salford Lung Study in chronic obstructive pulmonary disease
por: Bakerly, Nawar Diar, et al.
Publicado: (2021)

Loss of the neuroprotective factor Sphingosine 1-phosphate early in Alzheimer’s disease pathogenesis
por: Couttas, Timothy A, et al.
Publicado: (2014)

Biomarker discovery and development for frontotemporal dementia and amyotrophic lateral sclerosis
por: Katzeff, Jared S., et al.
Publicado: (2022)

Riluzole is associated with decreasing neuritic plaque severity in amyotrophic lateral sclerosis
por: Mazumder, Srestha, et al.
Publicado: (2022)

FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration
por: Urwin, Hazel, et al.
Publicado: (2010)

Discovery of SARS-CoV-2 main protease inhibitors using a synthesis-directed de novo design model
por: Morris, Aaron, et al.
Publicado: (2021)

Key Learnings from Running an Extension Study to a Real-World Effectiveness Trial: The Extended Salford Lung Study
por: Meeraus, Wilhelmine, et al.
Publicado: (2021)

Evidence supporting oxidative stress in a moderately affected area of the brain in Alzheimer’s disease
por: Youssef, Priscilla, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_181a2tanlft02ainb294di0tkg